Pricing Log in Create free account

Candel Therapeutics, Inc. (CADL) vs Kura Oncology, Inc. (KURA)

Candel Therapeutics, Inc. and Kura Oncology, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Kura Oncology, Inc. are of similar size ($615.2M and $604.9M). Candel Therapeutics, Inc. has the higher net margin (0.00% vs −384.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Candel Therapeutics, Inc. leads on 10 and Kura Oncology, Inc. on 5.

Valuation

Metric CADL KURA Biotechnology median
P/E n/m n/m 10.60
P/S 5,135.81 8.31 9.40
P/B 5.09 13.25 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 3,939.74 1.71 9.02
Earnings yield (16.28%) (46.68%) (32.88%)
Free cash flow yield (8.92%) (18.30%) (23.13%)

Profitability

Metric CADL KURA Biotechnology median
Gross margin 0.00% 99.35% 68.51%
Operating margin 0.00% (411.90%) 0.00%
Net margin 0.00% (384.30%) 0.00%
Free cash flow margin 0.00% (152.06%) 0.00%
Return on equity (81.84%) (167.71%) (51.96%)
Return on assets (56.37%) (46.73%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CADL KURA Biotechnology median
Revenue growth (TTM) 0.00% — 6.76%
EPS growth (last fiscal year) 58.62% (57.43%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CADL KURA Biotechnology median
Debt to equity 0.38 0.20 0.00
Current ratio 16.09 4.73 4.97
Net debt to EBITDA 1.53 2.11 1.01

Dividend

Metric CADL KURA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CADL KURA Biotechnology median
Market cap 615.21m 604.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack